AbSci’s $125 Million Crossover Financing

Martina Bellini
Tagged:

Goodwin Procter LLP advised AbSci on the deal.AbSci, a pioneering synthetic biology company that unifies biologic drug discovery and development processes, announced a $125 million crossover financing. The round…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now